Dawnrays Pharma hits 52-week low

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Dawnrays Pharma (2348.HK) slipped nearly 2% in Hong Kong trading to HK$0.8650, hitting a 52-week low intraday.

The stock is down 4.95% over the past ten sessions and down 25.24% year to date. It sits 27.13% below its 52-week high of HK$1.187. Volume was 6.11 times its average.

The Hang Seng Index is down 5.46% over the past five sessions and down 12.81% year to date.

The pharmaceuticals industry index fell 4.2% over the same period.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.